NCT05194566View on ClinicalTrials.gov

Neurostimulation for the Treatment of Post-Stroke Aphasia

NARecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 6, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Post-stroke Aphasia
Interventions
DEVICE

tACS

Neurostimulation will be done using the Neuro Device tCS (Neuro Device tCS), which is a certified transcranial electrical stimulator. The device consists of a stimulator with a touch screen, two electrodes and a soft, flexible cap to ensure stability of the electrodes on the head.

Trial Locations (2)

10029

RECRUITING

Abilities Research Center at Mount Sinai, New York

60611

RECRUITING

Think & Speak Lab at Shirley Ryan AbilityLab, Chicago

Sponsors

Lead Sponsor

Neuro Device S.A
All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Neuro Device S.A

INDUSTRY

NCT05194566 - Neurostimulation for the Treatment of Post-Stroke Aphasia | Biotech Hunter | Biotech Hunter